Select this product for Molecular Innovations name, Human PAI-1 (tPA specific mutant) and product number, HPAI-YSY. Human PAI-1 Recombinant tPA Specific from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: E. coli Storage Conditions: -70C Additional Information: A triple mutation (P3Tyr-P2Ser-P1Tyr) to wild-type Human PAI-1 that selectively inhibits tPA. Urokinase (uPA) inhibition is limited to 1/25,000 of tPA inhibition. This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.